These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34370832)

  • 1. Aspirin dosing for atherosclerotic cardiovascular disease: should we be more ADAPTABLE?
    Parker WAE; Storey RF
    Cardiovasc Res; 2021 Aug; 117(10):e123-e125. PubMed ID: 34370832
    [No Abstract]   [Full Text] [Related]  

  • 2. Fighting residual cardiovascular risk in stable patients with atherosclerotic vascular disease: COMPASS in context.
    Patrono C
    Cardiovasc Res; 2017 Dec; 113(14):e61-e63. PubMed ID: 29186439
    [No Abstract]   [Full Text] [Related]  

  • 3. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
    Maree AO; Fitzgerald DJ
    Circulation; 2007 Apr; 115(16):2196-207. PubMed ID: 17452618
    [No Abstract]   [Full Text] [Related]  

  • 4. [Efficacy and safety of various doses of acetylsalicylic Acid in prevention of complications of atherothrombosis].
    Komarov AL
    Kardiologiia; 2010; 50(10):56-61. PubMed ID: 21118181
    [No Abstract]   [Full Text] [Related]  

  • 5. Lower aspirin doses in dual antiplatelet therapy optimise efficacy and safety: CHARISMA follow-up study.
    Cardiovasc J Afr; 2009; 20(3):205. PubMed ID: 19575092
    [No Abstract]   [Full Text] [Related]  

  • 6. Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications.
    Spectre G; Arnetz L; Östenson CG; Brismar K; Li N; Hjemdahl P
    Thromb Haemost; 2011 Sep; 106(3):491-9. PubMed ID: 21800009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of platelet reactivity assessment in dual antiplatelet prophylaxis after transcatheter aortic valve implantation.
    Czerwińska-Jelonkiewicz K; Witkowski A; Dąbrowski M; Piotrowski W; Hryniewiecki T; Stępińska J
    Arch Cardiovasc Dis; 2018 Apr; 111(4):233-245. PubMed ID: 29126843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comments in response to "Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials".
    Fisher M; Knappertz V
    Am J Cardiol; 2005 Nov; 96(10):1467. PubMed ID: 16275203
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of aspirin dosing on the effects of P2Y12 inhibition in patients with acute coronary syndromes.
    Thomas MR; Storey RF
    J Cardiovasc Transl Res; 2014 Feb; 7(1):19-28. PubMed ID: 24309957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in monitoring of aspirin therapy.
    Lordkipanidzé M
    Platelets; 2012; 23(7):526-36. PubMed ID: 22873346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter by Fisher and Johns regarding article, "Variable platelet response to aspirin and clopidogrel in atherothrombotic disease".
    Fisher M; Johns T
    Circulation; 2007 Nov; 116(19):e521. PubMed ID: 17984385
    [No Abstract]   [Full Text] [Related]  

  • 12. Aspirin for primary prevention of cardiovascular disease: is it time to move on?
    Knickelbine T; Miedema MD
    Curr Opin Cardiol; 2019 Sep; 34(5):510-513. PubMed ID: 31219876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cilostazol shows promise as an alternative to aspirin for patients with ischaemic stroke.
    Hankey GJ
    Lancet Neurol; 2008 Jun; 7(6):469-70. PubMed ID: 18456559
    [No Abstract]   [Full Text] [Related]  

  • 14. Statins and aspirin in chronic kidney disease: what does the UK-HARP-I trial tell us?
    Krane V; Wanner C
    Am J Kidney Dis; 2005 Mar; 45(3):607-9. PubMed ID: 15754285
    [No Abstract]   [Full Text] [Related]  

  • 15. Aspirin resistance: is it real? Is it clinically significant?
    Dalen JE
    Am J Med; 2007 Jan; 120(1):1-4. PubMed ID: 17208069
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dose-response of aspirin on platelet function in very elderly patients].
    Feng XR; Liu ML; Liu F; Fan Y; Tian QP
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 48(5):835-840. PubMed ID: 27752166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin for the Primary Prevention of Cardiovascular Disease: Weighing Up the Evidence.
    Murphy S; McCarthy CP; McEvoy JW
    Am J Med; 2019 Sep; 132(9):1007-1008. PubMed ID: 30871925
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial.
    Legrand V; Cuisset T; Chenu P; Vrolix M; Martinez C; Dens J; Gach O; Boland J; Claeys MJ; Magne J; Barbato E; Wijns W
    EuroIntervention; 2014 Jun; 10(2):204-11. PubMed ID: 24952058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative aspirin therapy in non-cardiac surgery: A systematic review and meta-analysis of randomized controlled trials.
    Wolff G; Navarese EP; Brockmeyer M; Lin Y; Karathanos A; Kołodziejczak M; Kubica J; Polzin A; Zeus T; Westenfeld R; Andreotti F; Kelm M; Schulze V
    Int J Cardiol; 2018 May; 258():59-67. PubMed ID: 29544957
    [No Abstract]   [Full Text] [Related]  

  • 20. Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with Type 2 diabetes.
    Bethel MA; Harrison P; Sourij H; Sun Y; Tucker L; Kennedy I; White S; Hill L; Oulhaj A; Coleman RL; Holman RR
    Diabet Med; 2016 Feb; 33(2):224-30. PubMed ID: 26043186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.